Deadline to sign infusion letter looms

 - 
Thursday, January 19, 2017

WASHINGTON – The National Home Infusion Association seeks signatures for a letter that urges Congress to align the effective dates of switching to an average sales price reimbursement model for Part B infusion drugs.

In the letter, addressed to Senate Majority Leader Mitch McConnell, Senate Minority Leader Charles Schumer, House Speaker Paul Ryan and Democratic Leader Nancy Pelosi, the association requests “quick action” to ensure beneficiaries have access to services, equipment and drugs.

“The disconnect between these two provisions in the 21st Century Cures Act creates a four-year gap that needs to be closed,” states the letter. “Due to the required shift in drug reimbursement…Medicare emergency department, hospital, and infusion costs may increase for this population of beneficiaries.”

The ASP language was built in to the Cures Act to help “pay for” key elements of the Medicare Home Infusion Site of Care Act, which were also included in the bill.

Deadline for signatures is Jan. 24.